116 related articles for article (PubMed ID: 15287862)
21. Prognosis of early hepatocellular carcinoma after hepatic resection.
Maeda T; Shimada M; Harimoto N; Tsujita E; Aishima S; Tanaka S; Shirabe K; Maehara Y
Hepatogastroenterology; 2008; 55(85):1428-32. PubMed ID: 18795705
[TBL] [Abstract][Full Text] [Related]
22. Expression of vascular endothelial growth factor-C in human hepatocellular carcinoma.
Yamaguchi R; Yano H; Nakashima O; Akiba J; Nishida N; Kurogi M; Kojiro M
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):152-60. PubMed ID: 16706827
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological implications of immunohistochemically demonstrated mucin core protein expression in hepatocellular carcinoma.
Ichikawa T; Yamamoto T; Uenishi T; Tanaka H; Takemura S; Ogawa M; Tanaka S; Suehiro S; Hirohashi K; Kubo S
J Hepatobiliary Pancreat Surg; 2006; 13(3):245-51. PubMed ID: 16708303
[TBL] [Abstract][Full Text] [Related]
24. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
[TBL] [Abstract][Full Text] [Related]
25. [Expression and clinical significance of VEGF and MMP-9 in hepatocellular carcinoma].
Zhong C; Guo RP; Shi M; Wei W; Yu WS; Li JQ
Ai Zheng; 2006 May; 25(5):599-603. PubMed ID: 16687082
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinase-9,-3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer: relationship to clinicopathological variables.
Işlekel H; Oktay G; Terzi C; Canda AE; Füzün M; Küpelioğlu A
Cell Biochem Funct; 2007; 25(4):433-41. PubMed ID: 16615041
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection.
Yokoi Y; Suzuki S; Baba S; Inaba K; Konno H; Nakamura S
J Gastroenterol; 2005 Mar; 40(3):274-82. PubMed ID: 15830287
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic features of poorly differentiated hepatocellular carcinoma.
Oishi K; Itamoto T; Amano H; Fukuda S; Ohdan H; Tashiro H; Shimamoto F; Asahara T
J Surg Oncol; 2007 Mar; 95(4):311-6. PubMed ID: 17326126
[TBL] [Abstract][Full Text] [Related]
29. [Expression and clinical significance of certain apoptosis and angiogenesis factors in hepatocellular carcinoma].
Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ
Zhonghua Wai Ke Za Zhi; 2006 Dec; 44(23):1626-30. PubMed ID: 17359695
[TBL] [Abstract][Full Text] [Related]
30. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
Pesta M; Holubec L; Topolcan O; Cerna M; Rupert K; Holubec LS; Treska V; Kormunda S; Elgrova L; Finek J; Cerny R
Anticancer Res; 2005; 25(5):3387-91. PubMed ID: 16101153
[TBL] [Abstract][Full Text] [Related]
31. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
[TBL] [Abstract][Full Text] [Related]
32. Expression of matrix metalloproteinases (MMPs) in cultured hepatocellular carcinoma (HCC) cells and surgically resected HCC tissues.
Ogasawara S; Yano H; Momosaki S; Nishida N; Takemoto Y; Kojiro S; Kojiro M
Oncol Rep; 2005 Jun; 13(6):1043-8. PubMed ID: 15870919
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma.
Fukuda S; Itamoto T; Nakahara H; Kohashi T; Ohdan H; Hino H; Ochi M; Tashiro H; Asahara T
Hepatogastroenterology; 2005; 52(64):1163-7. PubMed ID: 16001653
[TBL] [Abstract][Full Text] [Related]
34. [Expression and clinical impact of vascular endothelial growth factor and matrix metalloproteinase-2 in hepatocellular carcinoma].
Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):285-8. PubMed ID: 16875630
[TBL] [Abstract][Full Text] [Related]
35. TIMP-3 gene transfection suppresses invasive and metastatic capacity of human hepatocarcinoma cell line HCC-7721.
Zhang H; Wang YS; Han G; Shi Y
Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):487-91. PubMed ID: 17897911
[TBL] [Abstract][Full Text] [Related]
36. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
[TBL] [Abstract][Full Text] [Related]
37. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
38. Invasion front-specific overexpression of tissue inhibitor of metalloproteinase-1 in liver metastases from colorectal cancer.
Kahlert C; Bandapalli OR; Schirmacher P; Weitz J; Brand K
Anticancer Res; 2008; 28(3A):1459-65. PubMed ID: 18630499
[TBL] [Abstract][Full Text] [Related]
39. Loss of claudin-1 expression correlates with malignancy of hepatocellular carcinoma.
Higashi Y; Suzuki S; Sakaguchi T; Nakamura T; Baba S; Reinecker HC; Nakamura S; Konno H
J Surg Res; 2007 May; 139(1):68-76. PubMed ID: 17270214
[TBL] [Abstract][Full Text] [Related]
40. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
